Patent · US Active

Compositions and methods for antibodies targeting BMP6

US11530261B2 · kind B2 · utility

0Cited by

12References

30Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Feng Cong · Quincy, US
William Dietrich · Cambridge, US
Nathalie George · Village-Neuf, FR
Dong Liu · Natick, US
Asher Schachter · Needham, US
Aditi Soni · Cambridge, US
Jing Zhou · Sichuan, CN

Key dates

Filing date	May 4, 2020
Grant date	Dec 20, 2022
Priority date	—
Expiry date	Dec 26, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to antibodies and antigen-binding fragments thereof to human BMP6 and compositions and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.